Mitsubishi UFJ Asset Management (UK)’s Alexion Pharmaceuticals ALXN Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$1.56M	–	92
2020 Q4	$1.56M	Hold	10,000	–	–	0.7%	50
2020 Q3	$1.14M	Sell	10,000 -10,000	-50%	-$1.08M	0.56%	54
2020 Q2	$2.24M	Hold	20,000	–	–	1.21%	27
2020 Q1	$1.79M	Buy	+20,000	New	+$1.96M	1.34%	29
2019 Q4	–	Sell	-19,000	Closed	-$1.86M	–	95
2019 Q3	$1.86M	Hold	19,000	–	–	0.87%	33
2019 Q2	$2.49K	Hold	19,000	–	–	0.03%	32
2019 Q1	$2.57K	Hold	19,000	–	–	0.03%	30
2018 Q4	$1.85M	Buy	19,000 +11,000	+138%	+$1.3M	0.93%	30
2018 Q3	$1.11K	Sell	8,000 -3,000	-27%	-$376K	0.03%	67
2018 Q2	$1.36M	Buy	+11,000	New	+$1.29M	0.77%	46

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s ALXN Position: Q1 2021 in Review

Mitsubishi UFJ Asset Management (UK) sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 10,000 shares — an estimated $1.56M sold.

Mitsubishi UFJ Asset Management (UK) first reported a position in ALXN in Q2 2018 and held it in 10 quarters. The position peaked at $2.24M in Q2 2020. 753 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

Mitsubishi UFJ Asset Management (UK) reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Mitsubishi UFJ Asset Management (UK) sold 10,000 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1.56M.
Mitsubishi UFJ Asset Management (UK) first reported a position in Alexion Pharmaceuticals in Q2 2018 and held it in 10 quarters.
Mitsubishi UFJ Asset Management (UK)'s Alexion Pharmaceuticals position peaked at $2.24M in Q2 2020.
753 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q1 2021, filed 21 Apr 2021.